X-73079229-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3

The NM_001012977.3(PABPC1L2A):​c.158C>G​(p.Pro53Arg) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 4)

Consequence

PABPC1L2A
NM_001012977.3 missense

Scores

3
5
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.89
Variant links:
Genes affected
PABPC1L2A (HGNC:27989): (poly(A) binding protein cytoplasmic 1 like 2A) Predicted to enable RNA binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.75

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PABPC1L2ANM_001012977.3 linkuse as main transcriptc.158C>G p.Pro53Arg missense_variant 1/1 ENST00000373519.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PABPC1L2AENST00000373519.1 linkuse as main transcriptc.158C>G p.Pro53Arg missense_variant 1/1 NM_001012977.3 P1

Frequencies

GnomAD3 genomes
Cov.:
4
GnomAD4 exome
Cov.:
4
GnomAD4 genome
Cov.:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 12, 2024The c.158C>G (p.P53R) alteration is located in exon 1 (coding exon 1) of the PABPC1L2A gene. This alteration results from a C to G substitution at nucleotide position 158, causing the proline (P) at amino acid position 53 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.038
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.099
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.027
D
MetaRNN
Pathogenic
0.75
D
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-7.3
D
REVEL
Uncertain
0.34
Sift
Uncertain
0.026
D
Sift4G
Benign
0.18
T
Vest4
0.69
MutPred
0.47
Gain of MoRF binding (P = 0.0076);
MVP
0.76
MPC
2.1
ClinPred
0.97
D
GERP RS
3.2
Varity_R
0.69
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-72299068; API